BUELOW ROLAND has a total of 18 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are THERAPEUTIC HUMAN POLYCLONALS INC, IMMUNOKICK INC and THERAPEUTIC HUMAN POLYCLONALS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 7 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Organic fine chemistry | |
#5 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Animal care | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations | |
#6 | Sugars | |
#7 | Materials for miscellaneous applications |
# | Name | Total Patents |
---|---|---|
#1 | Buelow Roland | 18 |
#2 | Platzer Josef | 5 |
#3 | Van Schooten Wim | 3 |
#4 | Schooten Wim V | 1 |
#5 | Iyer Suhasini | 1 |
#6 | Buelow Jens-Ulrich | 1 |
#7 | Tesi Raymond J | 1 |
#8 | Woo Jacky | 1 |
Publication | Filing date | Title |
---|---|---|
US2014056897A1 | Bispecific three-chain antibody-like molecules | |
WO2008027986A2 | Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals | |
US2009053210A1 | Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals | |
WO2006047367A2 | Suppression of endogenous immunoglubolin expression in non-human transgenic animals | |
WO2005038001A2 | Improved transgenesis by sperm-mediated gene transfer | |
WO2004072115A2 | Suppression of endogenous immunoglobulin expression in transgenic non-human animals expressing humanized or human antibodies | |
WO03072061A2 | Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |